- Report
- January 2024
- 161 Pages
Global
From €6620EUR$7,500USD£5,717GBP
- Report
- January 2024
- 189 Pages
Global
From €6620EUR$7,500USD£5,717GBP
- Report
- January 2024
- 133 Pages
Global
From €7017EUR$7,950USD£6,060GBP
- Drug Pipelines
- November 2023
- 30 Pages
United States
From €2427EUR$2,750USD£2,096GBP
- Report
- November 2023
- 92 Pages
Global
From €6620EUR$7,500USD£5,717GBP
- Report
- November 2023
- 262 Pages
Global
From €6620EUR$7,500USD£5,717GBP
- Report
- November 2023
- 30 Pages
Global
From €2869EUR$3,250USD£2,477GBP
- Report
- November 2023
- 30 Pages
Global
From €2427EUR$2,750USD£2,096GBP
- Drug Pipelines
- November 2023
- 30 Pages
United States
From €2427EUR$2,750USD£2,096GBP
- Drug Pipelines
- November 2023
- 30 Pages
United States
From €2427EUR$2,750USD£2,096GBP
- Drug Pipelines
- November 2023
- 30 Pages
United States
From €2427EUR$2,750USD£2,096GBP
- Report
- November 2023
- 200 Pages
Global
From €6620EUR$7,500USD£5,717GBP
- Report
- August 2023
- 76 Pages
Global
From €3487EUR$3,950USD£3,011GBP
- Report
- August 2023
- 166 Pages
Global
From €6620EUR$7,500USD£5,717GBP
- Report
- August 2023
- 80 Pages
Global
From €3487EUR$3,950USD£3,011GBP
- Report
- August 2023
- 217 Pages
Global
From €6620EUR$7,500USD£5,717GBP
- Report
- August 2023
- 150 Pages
United States
From €3310EUR$3,750USD£2,858GBP
- Drug Pipelines
- July 2023
- 30 Pages
Global
From €2427EUR$2,750USD£2,096GBP
- Report
- July 2023
- 67 Pages
Global
From €3487EUR$3,950USD£3,011GBP
- Report
- July 2023
- 128 Pages
Global
From €6620EUR$7,500USD£5,717GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more